Refusal of Venous Thromboembolism Prophylaxis and Incidence of Thrombosis in Patients with Cystic Fibrosis

Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2017, Vol 4, Issue 2

Abstract

Background Patients with cystic fibrosis (CF) are at risk of venous thromboembolism (VTE) during hospitalization but many refuse VTE prophylaxis. Methods A single-center, retrospective medical record review was conducted to determine the refusal rate of pharmacologic VTE prophylaxis in adult patients with CF and to identify any correlation between patients who refused prophylaxis and the incidence of VTE. Results Of the 426 patient encounters screened, 307 were included, representing 144 unique patients, with a mean age of 28.4±8.9 years. Venous thromboembolism prophylaxis was refused in 77.5% of the patient encounters. Refusal rates were similar for both unfractionated heparin and enoxaparin (78.8% vs. 75.0%). Five patients (1.63%) developed a VTE during hospitalization or within 30 days of discharge; all five patients refused VTE prophylaxis. Conclusions The majority of hospitalized patients with CF refused pharmacologic prophylaxis with no difference in refusal between pharmacologic agents, and the combined incidence of VTE was low.

Authors and Affiliations

Nicole L. Metzger

Keywords

Related Articles

Measurement of Activities of Daily Living in Patients with Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory lung disease characterized by progressive airway obstruction, which results in exertional dyspnea and physical disability. It is the third lead...

Cheyne-Stokes Respiration Revisited: Clinical Clue to the Diagnosis for Acute Exacerbation of Congestive Heart Failure

A 72-year-old man was admitted to the hospital to initiate chemotherapy for pleomorphic lung carcinoma (T4N0M1a, stage 4 cancer). He had a history of chronic systolic heart failure with severe mitral regurgitation diagno...

Rehabilitation in Patients Undergoing Lung Transplantation (LTx)

Lung transplantation (LTx) has become an established therapeutic option for treating patients with end-stage pulmonary disease. Before and after LTx, physical ability might be restricted due to certain effects on respira...

Significance of Molecular Genotyping for Lung Cancer in Modern Oncology

Lung cancer is one of the most prevalent life-threatening diseases and remains the leading cause of cancer-related death worldwide. Although surgical resection of the tumor is considered as one of the most effective trea...

The Relationship between Peripheral Arterial Disease and Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a representative chronic pulmonary disease and is predicted to become the third leading cause of death in middle-income countries by 2030.1 COPD has been recognized not on...

Download PDF file
  • EP ID EP546266
  • DOI 10.17140/PRRMOJ-4-138
  • Views 209
  • Downloads 0

How To Cite

Nicole L. Metzger (2017). Refusal of Venous Thromboembolism Prophylaxis and Incidence of Thrombosis in Patients with Cystic Fibrosis. Pulmonary Research and Respiratory Medicine – Open Journal, 4(2), 42-47. https://europub.co.uk/articles/-A-546266